secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED GUARDIAN INC (UG)
CIK:        0000101295
Form:       8-K
Filed at:   2024-08-09T23:59:59+00:00
Accession:  0001171843-24-004632
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United-Guardian Q2 2024 Sales Rise 28% to $3.39M, Net Income More Than Doubles to $956K
--------------------------------------------------------------------------------

- Net income for Q2 2024 was $956,225 ($0.21 per share) vs. $461,094 ($0.10 per share) in Q2 2023.
- Cosmetic ingredient sales surged 84% in Q2 and 115% for the first six months of 2024.
- Medical lubricant sales increased 15% in Q2 and 9% for the first half of 2024.
- Pharmaceutical sales rose 3% in Q2 but fell 13% for the six months due to Renacidin contract manufacturer shutdown; production resumed late March.
- Six-month sales reached $6.65 million and net income was $1.88 million, up from $5.22 million and $1.22 million a year earlier.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/101295/000117184324004632/0001171843-24-004632-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/101295/000117184324004632/f8k_080824.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-004632

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer